Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032 论文

2010Journal of Translational Medicine引用 249顶会
DOIPDF
Melanoma and MAPK PathwaysCytokine Signaling Pathways and InteractionsComputational Drug Discovery Methods
Computational Drug Discovery MethodsMelanoma and MAPK PathwaysCytokine Signaling Pathways and Interactions
相关技术:Computational Drug Discovery Methods
关系图谱

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032 · 作者

R

Ruth Halaban

D

Deepak Narayan

H

Harriet M. Kluger

A

Antonella Bacchiocchi

E

Elaine Cheng

S

Stephan Ariyan

A

Anna C. Pavlick

M

Mario Sznol

J

Jill C. Rubinstein